MDTrials
Board
1 director, last change in 2025Statutory director
appointed by deed of 10-04-2025
term without a fixed end
also on the board of 1 other company
listed in the 2025 annual accounts, filed on 06-01-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Artikel 17. Vertegenwoordiging van de vennootschap. Iedere bestuurder afzonderlijk, ook wanneer er meerdere bestuurders zijn…”deed of 10-04-2025
Mandates through the years
2 names, the dashed line is todayPeter Burggraeve
Statutory director
Statutory director
Katia VYNCKE
Successor statutory director
Successor statutory director
BoardEarlierend not dated
Mandates as a list
- Peter Burggraeve
- Statutory director, appointed by deed of 10-04-2025, still in office
- Katia VYNCKE
- Successor statutory director, appointed by deed of 10-04-2025, no longer listed in the 2025 annual accounts
Control
Shareholder
één aandeelhouder
This company
MDTrials
Equity €364,489
Profit €55,859 in 2025
Capital
- Contribution
- €3,000
- Source
- 2025 annual accounts
Articles of association
deed of 10-04-2025 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Alle handelingen nodig of dienstig voor vereffening, gewone meerderheid”
Shareholders
Stated in the deed
deed of 14-04-2025 ↗
- één aandeelhouder all shares